Alzheimer’s Disease – 17S-MC-HBEO
The PRESENCE-ALZ Study is looking to find out more about how safe an investigational drug is and whether it works in people with mild to moderate Alzheimer’s disease (AD).
We are inviting people who:
- Are 50-80 years of age
- Have had memory loss for 6 months or more that has become gradually worse over time and interferes with daily activities
- Have a family member or close friend who can be a reliable study partner, help keep track of taking the study drug every day, and attend some study appointments.
- Find out about a clinical study for people with mild to moderate Alzheimer’s diseaseThe study will last for about 8 months. Study-related drugs, health assessments, and medical tests will be provided.